Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population-Reference-Cited by-同舟云学术

Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population

Published:2021-08 Issue: Volume:Volume 15 Page:3341-3350
ISSN:1177-5483
Container-title:Clinical Ophthalmology
language:en
Short-container-title:OPTH

Author:

Pramanik Subhasish,Mondal Lakshmi Kanta^ORCID,Paine Suman Kalyan,Jain Sneha,Chowdhury Subhankar,Ganguly Upasana^ORCID,Ghosh Sayantan,Bose Chiranjit,Bhattacharjee Koena,Bhaduri Gautam

Publisher

Informa UK Limited

Subject

Ophthalmology

Reference33 articles.

1. Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration

2. Intravitreal Antiangiogenic Therapy of Uveitic Macular Edema: A Review

3. Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion

4. The Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular Edema Two-year results from a comparative effectiveness Randomized Clinical Trial. N Engl J Med. 2015;372:1193–1203. doi:10.1056/NEJMoa1414264

5. Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Résultats anatomiques et fonctionnels du protocole thérapeutique « 3 + PRN » dans le traitement de l’œdème maculaire diabétique;Journal Français d'Ophtalmologie;2024-09

2. Distance and near vision changes after intravitreal anti-vascular endothelial growth factor injection in eyes with center-involving diabetic macular edema;Indian Journal of Ophthalmology;2023-07

3. Real-World Outcomes of Anti-VEGF Therapy in Diabetic Macular Oedema: Barriers to Treatment Success and Implications for Low/Lower-Middle-Income Countries;Ophthalmology and Therapy;2023-02-23

4. Liposome-polyethylenimine complexes for the effective delivery of HuR siRNA in the treatment of diabetic retinopathy;Drug Delivery and Translational Research;2023-01-11

5. Small extracellular vesicle-loaded bevacizumab reduces the frequency of intravitreal injection required for diabetic retinopathy;Theranostics;2023